Cotrimoxazole 800Mg Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 80 mg trimethoprim / 400 mg sulfamethoxazole
Reference Brands: Bactrim, Septra(US & EU)
Category: Transplant
Cotrimoxazole tablets combine trimethoprim and sulfamethoxazole to inhibit bacterial folic acid synthesis, preventing DNA replication. It effectively treats urinary, respiratory, and skin infections. Benefits include broad-spectrum antibacterial activity, symptom relief, decreased infection transmission, and support for effectively managing urinary, respiratory, and skin bacterial infections.
Product Description:
Cotrimoxazole tablets, marketed as Bactrim and Septra, are approved in the US by the FDA and in the EU via EMA for treating bacterial infections including urinary tract, respiratory, and skin infections. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and worldwide availability of cotrimoxazole tablets, ensuring effective antibacterial therapy for patients across the globe.
Cotrimoxazole 800Mg Tablets — third party manufacturing & bulk supply
Cotrimoxazole 800Mg Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Cotrimoxazole 800Mg Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Cotrimoxazole 800Mg Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Cotrimoxazole 800Mg Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Cotrimoxazole Tablets are used to treat a wide range of bacterial infections, including urinary tract infections, respiratory tract infections, gastrointestinal infections, ear infections, and certain types of pneumonia. They are also used to prevent opportunistic infections in immunocompromised patients.
These tablets contain trimethoprim, which inhibits bacterial dihydrofolate reductase, and sulfamethoxazole, a sulfonamide that inhibits bacterial folic acid synthesis. Together, they work synergistically to stop bacterial growth and eliminate infection.
Trade names include Bactrim, Septra, Cotrim, and Sulfatrim depending on the region.
Cotrimoxazole Tablets are manufactured by multiple pharmaceutical companies worldwide, including Roche (Bactrim) and various generic manufacturers in India, LATAM, and Europe.
The generic name is trimethoprim + sulfamethoxazole.
Brand names include Bactrim, Septra, Cotrim, and Sulfatrim.
They are manufactured in countries such as the USA, India, EU, and LATAM by various pharmaceutical companies producing combination antibiotic therapy.
Related Products
Acyclovir Tablet
Strength:
200 mg, 400 mg, 800 mg
Form: Tablets
Reference Brands: Zovirax(US & EU)
View Details
Belatacept Injection
Strength:
250 mg/vial
Form: Injection
Reference Brands: Nulojix(US)
View Details
Basiliximab Injectable Solution
Strength:
20 mg/vial
Form: Injectable Solution
Reference Brands: Simulect(US)
View Details
Quick Response Guaranteed | Verified Suppliers
